fda glp-1 compounding warning october 2025 Compounded" drugs | Health Communication Research Laboratory FDA unleashes warning letters to

Henderson SJ, Konkar A, Hornigold DC, Trevaskis JL, Jackson R, Fritsch Fredin M, et al

Looking Ahead GLP-1 therapies are already reshaping how consumers approach food, influencing appetite, portion sizes and potentially flavour perception

Nuts and legume seeds for cardiovascular risk reduction: scientific evidence and mechanisms of action

For example, Wholesome Storys Myo-Inositol & D-Chiro Inositol + Folate combines MI with D-chiro-inositol (DCI) in a 40:1 ratio, a balance that has been studied specifically in people with PCOS.10 It also includes folate, which is commonly paired with inositol in PCOS research.1 But for broad, evidence-aligned effectiveness especially for general metabolic support or insulin sensitivity a straightforward MI supplement at a clinically relevant dose remains the most versatile option, which is why Life Extension earns the edge here

Circ Res (2012) 110(10):132235

A 2025 cohort study in JAMA Network Open found no significant association between preoperative GLP-1 receptor agonist use and short-term postoperative aspiration pneumonia among adults undergoing surgery